Paper42192576
The Prophylactic Effect of Dexmedetomidine 0.008% Versus Brimonidine 0.2% on IOP Elevation After Nd: YAG Laser Capsulotomy.
Zakeri P and 3 others. Pharmacol Res Perspect, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. The Prophylactic Effect of Dexmedetomidine 0.008% Versus Brimonidine 0.2% on IOP Elevation After Nd: YAG Laser Capsulotomy. Papers, record 42192576. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42192576
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Prophylactic Effect of Dexmedetomidine 0.008% Versus Brimonidine 0.2% on IOP Elevation After Nd: YAG Laser Capsulotomy.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dexmedetomidine | Major topic |
| Brimonidine Tartrate | Major topic |
| Intraocular Pressure | Major topic |
| Posterior Capsulotomy | Major topic |
| Humans | |
| Female | |
| Double-Blind Method | |
| Prospective Studies | |
| Male | |
| Ophthalmic Solutions | |
| Aged | |
| Lasers, Solid-State | |
| Capsule Opacification | |
| Adrenergic alpha-2 Receptor Agonists | |
| Postoperative Complications |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Ardabil University of Medical Sciences | PubMed |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25885718 | Efficacy and safety of dexmedetomidine as an additive to local anesthetics in peribulbar block for cataract surgery. | Anesth Essays Res | 2013 | https://conductscience.org/library/papers/25885718 | PubMed |
| 2 | 33595486 | Effect of dexmedetomidine on intraocular pressure as an additive in peribulbar block during glaucoma surgery. | Indian J Ophthalmol | 2021 | https://conductscience.org/library/papers/33595486 | PubMed |
| 3 | 20236252 | Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial. | Acta Ophthalmol | 2011 | https://conductscience.org/library/papers/20236252 | PubMed |
| 4 | 28261613 | The Effects of Intravenous Dexmedetomidine Injections on IOP in General Anesthesia Intubation: A Meta-Analysis. | Biomed Res Int | 2017 | https://conductscience.org/library/papers/28261613 | PubMed |
| 5 | 12658557 | Dorzolamide X apraclonidine in the prevention of the intraocular pressure spike after Nd : YAG laser posterior capsulotomy. | Curr Eye Res | 2002 | https://conductscience.org/library/papers/12658557 | PubMed |
| 6 | 16931262 | Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy. | J Cataract Refract Surg | 2006 | https://conductscience.org/library/papers/16931262 | PubMed |
| 7 | 24205938 | Benzalkonium chloride and glaucoma. | J Ocul Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24205938 | PubMed |
| 8 | 34753412 | The prophylactic effect of betaxolol 0.5% versus brimonidine 0.2% on IOP elevation after Nd:YAG laser posterior capsulotomy. | Clin Exp Optom | 2022 | https://conductscience.org/library/papers/34753412 | PubMed |
| 9 | 32944557 | Dexmedetomidine as an Additive to Local Anesthesia for Decreasing Intraocular Pressure in Glaucoma Surgery: A Randomized Trial. | Anesth Pain Med | 2020 | https://conductscience.org/library/papers/32944557 | PubMed |
| 10 | 32247310 | Perioperative Dexmedetomidine for outpatient cataract surgery: a systematic review. | BMC Anesthesiol | 2020 | https://conductscience.org/library/papers/32247310 | PubMed |
| 11 | 38623708 | Understanding the treatment paradigm and the sequencing of antiglaucoma fixed-dose combinations in a tertiary center in South India. | Indian J Ophthalmol | 2024 | https://conductscience.org/library/papers/38623708 | PubMed |
| 12 | 16808678 | Brimonidine 0.2% versus brimonidine Purite 0.15%: prophylactic effect on iop elevation after Nd:YAG laser posterior capsulotomy. | J Ocul Pharmacol Ther | 2006 | https://conductscience.org/library/papers/16808678 | PubMed |
| 13 | 32740512 | Effect of Intravenous Dexmedetomidine on Intraocular Pressure in Patients Undergoing Glaucoma Surgery Under Local Anesthesia: A Pilot Study. | J Glaucoma | 2020 | https://conductscience.org/library/papers/32740512 | PubMed |
| 14 | 29284835 | To Evaluate the Efficacy of Intravenous Infusion of Dexmedetomidine as Premedication in Attenuating the Rise of Intraocular Pressure Caused by Succinylcholine in Patients Undergoing Rapid Sequence Induction for General Anesthesia: A Randomized Study. | Anesth Essays Res | 2017 | https://conductscience.org/library/papers/29284835 | PubMed |
| 15 | 34720494 | Effect of Topical Dexmedetomidine (0.0055%) on Intraocular Pressure in Healthy Eyes: A Randomized Controlled Trial. | J Curr Glaucoma Pract | 2021 | https://conductscience.org/library/papers/34720494 | PubMed |
| 16 | 28924341 | Intraocular Pressure Spikes following Neodymium-doped Yttrium Aluminum Garnet Laser Capsulotomy: Current Prevalence and Management in Israel. | J Curr Glaucoma Pract | 2017 | https://conductscience.org/library/papers/28924341 | PubMed |
| 17 | 39033834 | Efficacy of Dexmedetomidine as an Adjuvant to Local Anesthetics in Peribulbar Block: A Meta-analysis With Trial-Sequential Analysis. | Am J Ophthalmol | 2025 | https://conductscience.org/library/papers/39033834 | PubMed |
| 18 | 17585375 | Prophylactic use of timolol maleate to prevent intraocular pressure elevation after Nd-YAG laser posterior capsulotomy. | Int Ophthalmol | 2008 | https://conductscience.org/library/papers/17585375 | PubMed |
| 19 | 39021405 | Effects of intramuscular alfaxalone and dexmedetomidine alone and combined on ocular, electroretinographic, and cardiorespiratory parameters in normal cats. | Front Vet Sci | 2024 | https://conductscience.org/library/papers/39021405 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42192576
GET https://conductscience.org/api/papers/v1/42192576/authors